BioCentury
ARTICLE | Company News

Modex gains exclusive license

March 6, 2001 8:00 AM UTC

Modex (SWX:MDXN) acquired from the Blood Transfusion Center (Lille, France) exclusive global rights to the use of fibrin glue-keratinocyte combinations for the treatment of wounds. Etablissement Frana...